TYENNE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65219-586 -
Package NDC
65219-586-04 -
Application number
BLA761275 -
SPL ID
aafc1dad-a64a-4dd7-9dfb-a10bd649ebc0 -
SPL set ID
ad76441d-da59-47df-8d9d-2243005180f0 -
UNII
I031V2H011 -
RxCUI
2686045 -
RxCUI
2686050 -
RxCUI
2686053 -
RxCUI
2686057
What the source publishes
- Labeler
- Fresenius Kabi USA, LLC
- Active ingredients
- Tocilizumab-aazg
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TYENNE",
"splId": "aafc1dad-a64a-4dd7-9dfb-a10bd649ebc0",
"labels": [
{
"setId": "ad76441d-da59-47df-8d9d-2243005180f0",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad76441d-da59-47df-8d9d-2243005180f0",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ad76441d-da59-47df-8d9d-2243005180f0"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Fresenius Kabi USA, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE, GLASS in 1 CARTON (65219-586-04) / .9 mL in 1 SYRINGE, GLASS",
"package_ndc": "65219-586-04",
"identifierStatus": "well-formed",
"marketing_end_date": "20261231",
"marketing_start_date": "20240701"
}
],
"productId": "65219-586_aafc1dad-a64a-4dd7-9dfb-a10bd649ebc0",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "65219-586",
"deaSchedule": null,
"genericName": "Tocilizumab-aazg",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TOCILIZUMAB",
"strength": "162 mg/.9mL"
}
],
"applicationNumber": "BLA761275",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240701",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000190478",
"N0000190480"
],
"unii": [
"I031V2H011"
],
"rxcui": [
"2686045",
"2686050",
"2686053",
"2686057"
],
"spl_set_id": [
"ad76441d-da59-47df-8d9d-2243005180f0"
],
"pharm_class_epc": [
"Interleukin-6 Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Interleukin 6 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Fresenius Kabi USA, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65219-586_aafc1dad-a64a-4dd7-9dfb-a10bd649ebc0"